Jaguar Animal Health Inc
Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress. The company operates through two segments, Animal Health and Human Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products. T… Read more
Jaguar Animal Health Inc (JAGX) - Total Assets
Latest total assets as of September 2025: $49.47 Million USD
Based on the latest financial reports, Jaguar Animal Health Inc (JAGX) holds total assets worth $49.47 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Jaguar Animal Health Inc - Total Assets Trend (2007–2024)
This chart illustrates how Jaguar Animal Health Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Jaguar Animal Health Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Jaguar Animal Health Inc's total assets of $49.47 Million consist of 60.3% current assets and 39.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 15.0% |
| Accounts Receivable | $1.65 Million | 3.1% |
| Inventory | $10.35 Million | 19.4% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $18.48 Million | 34.6% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2007–2024)
This chart illustrates how Jaguar Animal Health Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Jaguar Animal Health Inc's current assets represent 60.3% of total assets in 2024, a decrease from 79.4% in 2007.
- Cash Position: Cash and equivalents constituted 15.0% of total assets in 2024, up from 14.6% in 2007.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 34.0% of total assets, an increase from 14.0% in 2007.
- Asset Diversification: The largest asset category is intangible assets at 34.6% of total assets.
Jaguar Animal Health Inc Competitors by Total Assets
Key competitors of Jaguar Animal Health Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Jaguar Animal Health Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Jaguar Animal Health Inc generates 0.22x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Jaguar Animal Health Inc is currently not profitable relative to its asset base.
Jaguar Animal Health Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.81 | 1.84 | 1.35 |
| Quick Ratio | 0.52 | 1.36 | 1.14 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-6.72 Million | $ 16.77 Million | $ 4.57 Million |
Jaguar Animal Health Inc - Advanced Valuation Insights
This section examines the relationship between Jaguar Animal Health Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.12 |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | 5.2% |
| Total Assets | $53.42 Million |
| Market Capitalization | $1.26 Million USD |
Valuation Analysis
Below Book Valuation: The market values Jaguar Animal Health Inc's assets below their book value (0.02 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Jaguar Animal Health Inc's assets grew by 5.2% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Jaguar Animal Health Inc (2007–2024)
The table below shows the annual total assets of Jaguar Animal Health Inc from 2007 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $53.42 Million | +5.24% |
| 2023-12-31 | $50.76 Million | +6.98% |
| 2022-12-31 | $47.45 Million | -10.91% |
| 2021-12-31 | $53.27 Million | +24.33% |
| 2020-12-31 | $42.84 Million | +17.67% |
| 2019-12-31 | $36.41 Million | -11.29% |
| 2018-12-31 | $41.04 Million | -5.93% |
| 2017-12-31 | $43.63 Million | +1124.46% |
| 2016-12-31 | $3.56 Million | -71.28% |
| 2015-12-31 | $12.41 Million | +115.49% |
| 2014-12-31 | $5.76 Million | +1890.12% |
| 2013-12-31 | $289.26K | -97.19% |
| 2007-12-31 | $10.30 Million | -- |